Literature DB >> 2791709

Effect of intravenous vancomycin on renal function.

R H Eng1, L Wynn, S M Smith, F Tecson-Tumang.   

Abstract

In the past, vancomycin has been reported to cause renal failure during intravenous administration; however, more recently, such renal toxicity is alleged not to occur because of increased purity of the vancomycin preparations. In this study, 23 patients were prospectively examined during intravenous vancomycin administration for changes in renal function. Vancomycin was administered for an average of 15 days. The blood urea nitrogen (BUN) changes averaged +1.7 mg/dl and the creatinine changes averaged +0.06 mg/dl. Since the accuracy of the serum creatinine determination was +/- 0.3 mg/dl, clinically significant deterioration of renal function occurred in 4 patients or 17%. Even among these 4 patients with documented worsening of renal function, we suspect that deterioration was related to the infection being treated. With close monitoring of dosing, the propensity of vancomycin to cause nephrotoxicity may be less than once thought.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791709     DOI: 10.1159/000238688

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  7 in total

1.  Pulmonary disposition of vancomycin in critically ill patients.

Authors:  H Georges; O Leroy; S Alfandari; B Guery; M Roussel-Delvallez; C Dhennain; G Beaucaire
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 2.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

3.  Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Pengxin Lin; Karim Calis; Amy M Kelaher; Heidi A Muray; Christine Mya-San; Diana Mickiene; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Vancomycin administration: the impact of multidisciplinary interventions.

Authors:  R K Crowley; F Fitzpatrick; D Solanki; S FitzGerald; H Humphreys; E G Smyth
Journal:  J Clin Pathol       Date:  2007-02-09       Impact factor: 3.411

Review 5.  Glycopeptides and nephrotoxicity.

Authors:  A W Chow; R M Azar
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

6.  Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling.

Authors:  D Beauchamp; P Gourde; M Simard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

7.  Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates.

Authors:  Christine Dieterich; Angela Puey; Sylvia Lin; Sylvia Lyn; Robert Swezey; Anna Furimsky; David Fairchild; Jon C Mirsalis; Hanna H Ng
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.